{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T14:31:53Z","timestamp":1781015513154,"version":"3.54.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>In pancreatic islet transplantation, the exact contribution of human leukocyte antigen (HLA) matching to graft survival remains unclear. Islets may be exposed to allogenic rejection but also the recurrence of type 1 diabetes (T1D). We evaluated the HLA-DR matching, including the impact of diabetogenic HLA-DR3 or HLA-DR4 matches.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively examined the HLA profile in 965 transplant recipients and 2327 islet donors. The study population was obtained from patients enrolled in the Collaborative Islet Transplant Registry. We then identified 87 recipients who received a single-islet infusion. Islet-kidney recipients, 2nd islet infusion, and patients with missing data were excluded from the analysis (n=878).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>HLA-DR3 and HLA-DR4 were present in 29.7% and 32.6% of T1D recipients and 11.6% and 15.8% of the donors, respectively. We identified 52 T1D islet recipients mismatched for HLA-DR (group A), 11 with 1 or 2 HLA-DR-matches but excluding HLA-DR3 and HLA- DR4 (group B), and 24 matched for HLA-DR3 or HLA-DR4 (group C). Insulin-independence was maintained in a significantly higher percentage of group B recipients from year one through five post-transplantation (p&amp;lt;0.01). At five-year post-transplantation, 78% of group B was insulin-independent compared to 24% (group A) and 35% (group C). Insulin-independence correlated with significantly better glycemic control (HbA1c &amp;lt;7%), fasting blood glucose, and reduced severe hypoglycemic events. Matching HLA-A-B-DR (\u22653) independently of HLA- DR3 or HLA-DR4 matching did not improve graft survival.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study suggests that matching HLA-DR but excluding the diabetogenic HLA-DR3 and\/or 4 is a significant predictor for long-term islet survival.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1110544","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T09:03:41Z","timestamp":1679475821000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantation"],"prefix":"10.3389","volume":"14","author":[{"given":"Cassandra","family":"Ballou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth H.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Berney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Villard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael P. H.","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Baidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Alejandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Robien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Eggerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malek","family":"Kamoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick D.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4161\/self.2.1.15422","article-title":"Transplantation tolerance: Clinical potential of regulatory T cells","volume":"2","author":"Muller","year":"2011","journal-title":"Self Nonself"},{"key":"B2","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.it.2016.08.010","article-title":"Present yourself! by MHC class I and MHC class II molecules","volume":"37","author":"Rock","year":"2016","journal-title":"Trends Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/jcp.2009.072785","article-title":"HLA and kidney transplantation","volume":"63","author":"Clark","year":"2010","journal-title":"J Clin Pathol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/ki.2014.106","article-title":"Impact of donor mismatches at individual HLA-a, -b, -c, -DR, and -DQ loci on the development of HLA-specific antibodies in patients listed for repeat renal transplantation","volume":"86","author":"Kosmoliaptsis","year":"2014","journal-title":"Kidney Int"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00575","article-title":"HLA mismatching strategies for solid organ transplantation - a balancing act","volume":"7","author":"Zachary","year":"2016","journal-title":"Front Immunol"},{"key":"B6","first-page":"334","article-title":"HLA compatibility and organ transplant survival. collaborative transplant study","volume":"1","author":"Opelz","year":"1999","journal-title":"Rev Immunogenet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/01.tp.0000269725.74189.b9","article-title":"Effect of human leukocyte antigen compatibility on kidney graft survival: Comparative analysis of two decades","volume":"84","author":"Opelz","year":"2007","journal-title":"Transplantation"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.2337\/db10-0076","article-title":"Genetics of type 1 diabetes: What\u2019s next","volume":"59","author":"Pociot","year":"2010","journal-title":"Diabetes"},{"key":"B9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/TP.0b013e31829b080f","article-title":"Quantification of islet loss and graft functionality during immune rejection by 3-tesla MRI in a rat model","volume":"96","author":"Borot","year":"2013","journal-title":"Transplantation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/TP.0b013e31820385e6","article-title":"Influence of donor age on islet isolation and transplantation outcome","volume":"91","author":"Niclauss","year":"2011","journal-title":"Transplantation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/tri.13725","article-title":"Pancreas collagen digestion during islet of langerhans isolation-a prospective study","volume":"33","author":"Meier","year":"2020","journal-title":"Transpl Int"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/ajt.12138","article-title":"Transplanted human pancreatic islets after long-term insulin independence","volume":"13","author":"Muller","year":"2013","journal-title":"Am J Transplant"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000651","article-title":"Absence of amyloid deposition in human islets transplantation after 13 years insulin independence","volume":"99","author":"Muller","year":"2015","journal-title":"Transplantation"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16637","article-title":"Ten-year outcomes of islet transplantation in patients with type 1 diabetes: Data from the Swiss-French GRAGIL network","volume":"21","author":"Lablanche","year":"2021","journal-title":"Am J Transplant"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.2337\/dc15-1988","article-title":"Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia","volume":"39","author":"Hering","year":"2016","journal-title":"Diabetes Care"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.2337\/dc12-2480","article-title":"Hypoglycemia and diabetes: A report of a workgroup of the American diabetes association and the endocrine society","volume":"36","author":"Seaquist","year":"2013","journal-title":"Diabetes Care"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.2337\/dc12-0063","article-title":"Improvement in outcomes of clinical islet transplantation: 1999-2010","volume":"35","author":"Barton","year":"2012","journal-title":"Diabetes Care"},{"key":"B18","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.humimm.2008.06.007","article-title":"Autoimmune-associated HLA-B8-DR3 haplotypes in Asian indians are unique in C4 complement gene copy numbers and HSP-2 1267A\/G","volume":"69","author":"Kaur","year":"2008","journal-title":"Hum Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.670844","article-title":"Segregation analysis of genotyped and family-phased, long range MHC classical class I and class II haplotypes in 5 families with type 1 diabetes proband in the united Arab Emirates","volume":"12","author":"Tay","year":"2021","journal-title":"Front Genet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.2337\/dc18-0087","article-title":"A type 1 diabetes genetic risk score predicts progression of islet autoimmunity and development of type 1 diabetes in individuals at risk","volume":"41","author":"Redondo","year":"2018","journal-title":"Diabetes Care"},{"key":"B21","doi-asserted-by":"publisher","first-page":"ii48","DOI":"10.1093\/ndt\/gfh1082","article-title":"Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation","volume":"20","author":"Berney","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"B22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5414\/CNP57027","article-title":"HLA matching for simultaneous pancreas-kidney transplantation in the united states: a multivariable analysis of the UNOS data","volume":"57","author":"Mancini","year":"2002","journal-title":"Clin Nephrol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/tri.14138","article-title":"Association of human leukocyte antigen mismatches between donor-recipient and donor-donor in pancreas after kidney transplant recipients","volume":"34","author":"Parajuli","year":"2021","journal-title":"Transpl Int"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1111\/ajt.13734","article-title":"HLA-a, -b, -c, -DR, and -DQ matching in pancreas transplantation: Effect on graft rejection and survival","volume":"16","author":"Rudolph","year":"2016","journal-title":"Am J Transplant"},{"key":"B25","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/00007890-199110000-00016","article-title":"Major-histocompatibility-complex restricted and nonrestricted autoimmune effector mechanisms in BB rats","volume":"52","author":"Markmann","year":"1991","journal-title":"Transplantation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.2337\/diabetes.51.11.3202","article-title":"The role of autoimmunity in islet allograft destruction: Major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade","volume":"51","author":"Makhlouf","year":"2002","journal-title":"Diabetes"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMc061530","article-title":"Autoimmunity after islet-cell allotransplantation","volume":"355","author":"Sharma","year":"2006","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1097\/00007890-199604270-00027","article-title":"Evidence of recurrent autoimmunity in human allogeneic islet transplantation","volume":"61","author":"Stegall","year":"1996","journal-title":"Transplantation"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1097\/TP.0b013e3181bc06b0","article-title":"Histologic graft assessment after clinical islet transplantation","volume":"88","author":"Toso","year":"2009","journal-title":"Transplantation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1006\/jaut.1996.0051","article-title":"Number of autoantibodies (against insulin, GAD or ICA512\/IA2) rather than particular autoantibody specificities determines risk of type I diabetes","volume":"9","author":"Verge","year":"1996","journal-title":"J Autoimmun"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.2337\/dc11-0560","article-title":"Development of autoantibodies in the TrialNet natural history study","volume":"34","author":"Vehik","year":"2011","journal-title":"Diabetes Care"},{"key":"B32","doi-asserted-by":"publisher","first-page":"dc201836","DOI":"10.2337\/dc20-1836","article-title":"Islet autoimmunity and HLA markers of presymptomatic and clinical type 1 diabetes: Joint analyses of prospective cohort studies in Finland, Germany, Sweden, and the U.S","author":"Anand","year":"2021","journal-title":"Diabetes Care"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.2337\/dc16-2228","article-title":"Twenty-year progression rate to clinical onset according to autoantibody profile, age, and HLA-DQ genotype in a registry-based group of children and adults with a first-degree relative with type 1 diabetes","volume":"40","author":"Gorus","year":"2017","journal-title":"Diabetes Care"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1111\/ajt.15322","article-title":"Noninvasive diagnosis of recurrent autoimmune type 1 diabetes after islet cell transplantation","volume":"19","author":"Korutla","year":"2019","journal-title":"Am J Transplant"},{"key":"B35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/ajt.13426","article-title":"Risk factors for type 1 diabetes recurrence in immunosuppressed recipients of simultaneous pancreas-kidney transplants","volume":"16","author":"Vendrame","year":"2016","journal-title":"Am J Transplant"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1007\/s00125-021-05513-4","article-title":"DR15-DQ6 remains dominantly protective against type 1 diabetes throughout the first five decades of life","volume":"64","author":"Thomas","year":"2021","journal-title":"Diabetologia"},{"key":"B37","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/intimm\/dxp039","article-title":"Prediction of HLA-DQ8beta cell peptidome using a computational program and its relationship to autoreactive T cells","volume":"21","author":"Chang","year":"2009","journal-title":"Int Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2337\/db14-0858","article-title":"Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4+ T cells infiltrate islets in type 1 diabetes","volume":"64","author":"Pathiraja","year":"2015","journal-title":"Diabetes"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1110544\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T09:03:45Z","timestamp":1679475825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1110544\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,21]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2023.1110544"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1110544","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,21]]},"article-number":"1110544"}}